Ortho Institute - Prostaatkanker

Orthomolecular library

Links to 4388 Pubmed-abstracts of human studies.
Orthomolecular selection criteria; categorized on illnesses.

Translation

Dear visitor, if you see any mistakes in the version of this website in your language, please do not hesitate to contact us.

Languages

Home › Orthomolecular library

Prostate cancer (76)

2010 - Watters JL, Gail MH, [..], Albanes D. Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival. Cancer Res 2009; 69(9):3833-41

2010 - Touré A, Xueming X. Flaxseed Lignans: Source, Biosynthesis, Metabolism, Antioxidant Activity, Bio-Active Components, and Health Benefits. Comprehensive Reviews in Food Science and Food Safety 2010; 9(3):261-69

2010 - Nimptsch K, Rohrmann S, [..], Linseisen J. Dietary vitamin K intake in relation to cancer incidence and mortality: results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). Am J Clin Nutr 2010; 91(5):1348-58

2009 - Jain SK, Rains J, [..], Jones K. Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxid Redox Signal 2009; 11(2):241-9

2009 - Tretli S, Hernes E, [..], Robsahm TE. Association between serum 25(OH)D and death from prostate cancer. Br J Cancer 2009; 100(3):450-4

2009 - Tsavachidou D, McDonnell TJ, [..], Kim J. Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst 2009; 101(5):306-20

2009 - Lewis JE, Soler-Vilá H, [..], Hu JJ. Intake of plant foods and associated nutrients in prostate cancer risk. Nutr Cancer 2009; 61(2):216-24

2009 - Fradet V, Cheng I, [..], Witte JS. Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin Cancer Res 2009; 15(7):2559-6

2009 - Nimptsch K, Rohrmann S, [..], Linseisen J. Serum undercarboxylated osteocalcin as biomarker of vitamin K intake and risk of prostate cancer: a nested case-control study in the Heidelberg cohort of the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2009; 18:49-56

2009 - Muecke R, Klotz T, [..], Micke O. Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH. Acta Oncol 2009; 48(3):452-6

2009 - Bidoli E, Talamini R, [..], La Vecchia C. Dietary vitamins E and C and prostate cancer risk. Acta Oncol 2009: 1-5

2009 - McLarty J, Bigelow RL, [..], Cardelli JA. Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prev Res (Phila Pa) 2009; 2(7):673-82

2009 - Kasperzyk JL, Fall K, [..], Andrén O. One-carbon metabolism-related nutrients and prostate cancer survival. Am J Clin Nutr 2009; 90(3):561-9

2009 - Rhee HV, Coebergh JW, Vries ED. Sunlight, vitamin D and the prevention of cancer: a systematic review of epidemiological studies. Eur J Cancer Prev 2009 Aug 26 [Epub ahead of print]

2008 - Duffy KB, Spangler EL, [..], Ingram DK. A blueberry-enriched diet provides cellular protection against oxidative stress and reduces a kainate-induced learning impairment in rats. Neurobiol Aging 2008; 29(11):1680-9

2008 - Panza VS, Wazlawik E, Ricardo Schütz G, Comin L, Hecht KC, da Silva EL. Consumption of green tea favorably affects oxidative stress markers in weight-trained men. Nutrition 2008; 24(5):433-42

2008 - Cooke M, Iosia M, [..], Kreider R. Effects of acute and 14-day coenzyme Q10 supplementation on exercise performance in both trained and untrained individuals. J Int Soc Sports Nutr 2008; 5:8

2008 - El-Beshlawy A, Youssry I,[..], Taher A. Pulmonary hypertension in beta-thalassemia major and the role of L-carnitine therapy. Pediatr Hematol Oncol 2008; 25(8):734-43

2008 - Kurahashi N, Iwasaki M, [..], Tsugane S. Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center. J Clin Oncol 2008; 26(36):5923-9

2007 - Lawson KA, Wright ME, Subar A, Mouw T, Hollenbeck A, Schatzkin A, Leitzmann MF. Multivitamin Use and Risk of Prostate Cancer in the National Institutes of Health–AARP Diet and Health Study. JNCI 2007; 99(10):754-764

2007 - Canene-Adams K, Lindshield BL, Wang S, Jeffery EH, Clinton SK, Erdman JW Jr. Combinations of tomato and broccoli enhance antitumor activity in dunning r3327-h prostate adenocarcinomas. Cancer Res 2007; 67(2):836-43

2007 - Weinstein SJ, Wright ME, Lawson KA, Snyder K, Männistö S, Taylor PR, Virtamo J, Albanes D. Serum and dietary vitamin e in relation to prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2007; 16(6):1253-9

2007 - John EM, Koo J, Schwartz GG. Sun exposure and prostate cancer risk: evidence for a protective effect of early-life exposure. Cancer Epidemiol Biomarkers Prev 2007; 16(6):1283-6

2007 - Hallahan B, Hibbeln JR, Davis JM, Garland MR. Omega-3 fatty acid supplementation in patients with recurrent self-harm. Single-centre double-blind randomised controlled trial. Br J Psychiatry 2007; 190:118-22

2007 - Grigorian A, Lee SU, Tian W, Chen IJ, Gao G, Mendelsohn R, Dennis JW, Demetriou M. Control of T Cell-mediated autoimmunity by metabolite flux to N-glycan biosynthesis. J Biol Chem 2007; 282(27):20027-35

2007 - Prasad AS, Beck FW, Bao B, Fitzgerald JT, Snell DC, Steinberg JD, Cardozo LJ. Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr. 2007; 85(3):837-44

2007 - Natella F, Fidale M, Tubaro F, Ursini F, Scaccini C. Selenium supplementation prevents the increase in atherogenic electronegative LDL (LDL minus) in the postprandial phase. Nutr Metab Cardiovasc Dis 2007; 17(9):649-56

2007 - Jacobs EJ, et al. Cholesterol-lowering drugs and advanced prostate cancer incidence in a large US cohort. Cancer Epidemiology, Biomarkers and Prevention 2007; 16:2212-2217; Flick ED, et al. Statin use and risk of prostate cancer in the California Men’s Health Study Cohort. Cancer Epidemiology, Biomarkers and Prevention 2007; 16:2218-2225; Murtola TJ, et al. Cholesterol-lowering drugs and prostate cancer risk: A population-based study. Cancer Epidemiology, Biomarkers and Prevention 2007;16:2226-2232

2007 - Loffredo L, Marcoccia A, Pignatelli P, Andreozzi P, Borgia MC, Cangemi R, Chiarotti F, Violi F Oxidative-stress-mediated arterial dysfunction in patients with peripheral arterial disease. Eur Heart J 2007; 28(5):608-612

2007 - Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, Curhan GC. Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension. Hypertension 2007; 49:1063-9

2007 - Nöthlings U, Murphy SP, [..], Kolonel LN. Flavonols and Pancreatic Cancer Risk: The Multiethnic Cohort Study. Am J Epidemiol 2007; 166(8):924-31

2006 - Galeone C, Pelucchi C, Levi F, Negri E, Franceschi S, Talamini R, Giacosa A, La Vecchia C. Onion and garlic use and human cancer. Am J Clin Nutr 2006; 84(5):1027-32

2003 - Dunlap N, Schwartz GG, Eads D, Cramer SD, Sherk AB, John V, Koumenis C. 1alpha,25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha,25(OH)(2)D(2), potentiate the effects of ionising radiation on human prostate cancer cells Br J Cancer 2003; 89(4):746-53

2003 - Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willett WC, Giovannucci EL.Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst 2003; 95(13):1004-7

2003 - Boileau TW, Liao Z, Kim S, Lemeshow S, Erdman JW Jr, Clinton SK. Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets. J Natl Cancer Inst 2003; 95(21):1578-86

2003 - Ansari MS, Gupta NP. A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer. BJU Int 2003; 92(4):375-8

2003 - Virtamo J, Pietinen P, Huttunen JK, Korhonen P, Malila N, Virtanen MJ, Albanes D, Taylor PR, Albert P; ATBC Study Group. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA 2003; 290(4):476-85.

2003 - Alavanja MC, Samanic C, Dosemeci M, Lubin J, Tarone R, Lynch CF, Knott C, Thomas K, Hoppin JA, Barker J, Coble J, Sandler DP, Blair A. Use of agricultural pesticides and prostate cancer risk in the Agricultural Health Study cohort. Am J Epidemiol 2003; 157: 800-14

2002 - Woodson K, Triantos S, Hartman T, Taylor PR, Virtamo J, Albanes D. Long-term alpha-tocopherol supplementation is associated with lower serum vascular endothelial growth factor levels. Anticancer Res 2002; 22(1A):375-378

2002 - Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC. A prospective study of tomato products, lycopene, and prostate cancer risk. Journal of the National Cancer Institute 2002; 94(5):391-398.

2002 - Grant WB. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002;94(6):1867-1875.

2002 - Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennett CJ, Ewing CM, Platz EA, Ferdinandusse S, Wanders RJ, Trent JM, Isaacs WB, De Marzo AM. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res 2002; 62(8):2220-2226

2002 - Zhang Y, Ni J, Messing EM, Chang E, Yang CR, Yeh S. Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells. Proc Natl Acad Sci USA. 2002; 99(11):7408-13

2002 - Vogt TM, Mayne ST, Graubard BI, Swanson CA, Sowell AL, Schoenberg JB, Swanson GM, Greenberg RS, Hoover RN, Hayes RB, Ziegler RG. Serum lycopene, other serum carotenoids, and risk of prostate cancer in US Blacks and Whites. Am J Epidemiol 2002; 155(11):1023-1032

2002 - Kristal AR, Cohen JH, Qu P, Stanford JL. Associations of energy, fat, calcium, and vitamin D with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2002; 11(8):719-725

2002 - Shike M, Latkany L, Riedel E, Fleisher M, Schatzkin A, Lanza E, Corle D, Begg CB. Lack of effect of a low-fat, high-fruit, -vegetable, and -fiber diet on serum prostate-specific antigen of men without prostate cancer: results from a randomized trial. J Clin oncol 2002;20:3592-8

2002 - Seo YR, Kelley MR, Smith ML. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc Natl Acad Sci USA 2002; 99:14548-53

2002 - Hsing AW, Chokkalingam AP, Gao YT, Madigan MP, Deng J, Gridley G, Fraumeni JF Jr. Allium vegetables and risk of prostate cancer: a population-based study. J Natl Cancer Inst 2002; 94(21):1648-1651

2002 - deVere White RW, Hackman RM, Soares SE, Beckett LA, Sun B. Effects of a mushroom mycelium extract on the treatment of prostate cancer. Urology 2002; 60(4):640-644

2002 - Kucuk O, Sarkar FH, Djuric Z, Sakr W, Pollak MN, Khachik F, Banerjee M, Bertram JS, Wood DP Jr. Effects of lycopene supplementation in patients with localized prostate cancer. Exp Biol Med 2002; 227(10):881-885

2001 - Terry P, Lichtenstein P, Feychting M, Ahlbom A, Wolk A. Fatty fish consumption and risk of prostate cancer.Lancet. 2001; 357(9270):1764-6

2001 - Demark-Wahnefried W, Price DT, Polascik TJ, Robertson CN, Anderson EE, Paulson DF, Walther PJ, Gannon M, Vollmer RT. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen and histopathologic features. Urology 2001; 58: 47-52

2001 - Tymchuk CN, Barnard RJ, Heber D, Aronson WJ. Evidence of an inhibitory effect of diet and exercise on prostate cancer cell growth. J Urol. 2001; 166(3):1185-9

2001 - Chan JM, Stampfer MJ, Ma J, Gann PH, Gaziano JM, Giovannucci EL. Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. American Journal of Clinical Nutrition. 2001; 74:549-554

2001 - Saxe GA, Hebert JR, Carmody JF, Kabat-Zinn J, Rosenzweig PH, Jarzobski D, Reed GW, Blute RD. Can diet in conjunction with stress reduction affect the rate of increase in prostate specific antigen after biochemical recurrence of prostate cancer? Journal of Urology 2001; 166:2202-2207

2001 - Books JD et al. Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urology 2001; 166:2034- 2038

2001 - Kucuk O, Sarkar FH, Sakr W, Djuric Z, Pollak MN, Khachik F, Li YW, Banerjee M, Grignon D, Bertram JS, Crissman JD, Pontes EJ, Wood DP Jr. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiolol Biomarkers Prev 2001; 10:861-868

2000 - Norrish AE. et al. Prostate cancer and dietary carotenoids. Am J Epidemiol. 2000; 15;151(2):119-23.

2000 - Tavani A, La Vecchia C, et al. Red meat intake and cancer risk: A study in Italy. Int J Cancer 2000; 86:425-428

2000 - Helzlsouer KJ, et al. Association Between -Tocopherol, -Tocopherol, Selenium, and Subsequent Prostate Cancer. Journal of the National Cancer Institute 2000; 92:2018-2023

1998 - Journal of Clinical Oncology 1998; 16:3649-3655

1998 - BMJ 1998; 317:1636-1640

1998 - Zock, P.L. Katan, M.B. Linoleic acid intake and cancer risk: a review and meta analysis. American Journal of Clinical Nutrition 1998; 68:142-53

1998 - Yoshizawa K. et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Nat Canc Inst.1998;90:1219-1224.

1997 - Bakker N. et al. Adipose fatty acids and cancers of the breast, prostate and colon: an ecological study. International Journal of Cancer 1997;72:587-591.

1997 - Sigounas G et al. DL-alfatocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. Nutrition and Cancer 1997;28,1:30-35.

1996 - Eichholzer M et al. Prediction of male cancer mortality by plasma levels of the interacting vitamins: 17-year follow-up of the prospective Basel study. International Journal of Cancer 1996;66:145-150.

1996 - Godley PA et al. Biomarkers of essential fatty acid consumption and risk of prostatic carcinoma. Cancer Epidemiology, Biomarkers & Prevention 1996;5:889-895.

1995 - Flagg EW et al. Epidemiologic studies of antioxidants and cancer in humans. Journal of the American College of Nutrition 1995;14:419-427.

1995 - Hayes RB. Are dietary fat and vasectomy risk factors for prostate cancer? Journal of the National Cancer Institute 1995;87:629-631. Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, Burch JD, Hankin J, Dreon DM, West DW, et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 1995; 87(9):652-61

1995 - Giovannucci E et al. Intake of carotenoids and retinol in relation to risk of prostate cancer. Journal of the National Cancer Institute 1995;87:1767-1776.

1995 - Berges R et al. Randomised, placebo-controlled, double-blind clinical trial of B-Sitosterol in patients with benigne prostatic hyperplasia. The Lancet 1995;345:1529-1532.

1994 - Nutrition and Cancer 1994;21:113-131

1994 - Greenwald P. Annals of Medicine 1994;26:73-80.

1994 - Gann P.H. et al. Journal of National Cancer Institute 1994:86(4):281-286

1994 - Ross R.K. et al. Journal of the National Cancer Institute 1994;86(4):252-254